Home Featured Page 272

Featured

Latest

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in Parliamentary Report

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

Exploring Psychedelist with Louis Dorian

Magic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common Side Effects

Psychedelic Business News Spotlight: February 12, 2021

The Structure-Activity Relationship of Psilocybin Analogs

New Jersey Gov Signs Bill Reclassifying Psilocybin

PTSF 46 – Patents, Prohibition, Health, and Happiness

New Age Animism: A Consciousness Theory With a Psychedelic Twist

Progressive Doctor Thinks Psychedelics May Be Used to Revive Comatose Patients

MINDCURE Announces Listing of Warrants

PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke

Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds...

1...271272273...281 Page 272 of 281

EDITOR PICKS

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in Parliamentary Report

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

Exploring Psychedelist with Louis Dorian

Magic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common Side Effects

Psychedelic Business News Spotlight: February 12, 2021

The Structure-Activity Relationship of Psilocybin Analogs

New Jersey Gov Signs Bill Reclassifying Psilocybin

PTSF 46 – Patents, Prohibition, Health, and Happiness

New Age Animism: A Consciousness Theory With a Psychedelic Twist

Progressive Doctor Thinks Psychedelics May Be Used to Revive Comatose Patients

MINDCURE Announces Listing of Warrants

PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke

Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds...

EDITOR PICKS

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY